Case Number:

IPR2022-00817

Case Type:

IPR

Status:

Final Written Decision - Appealed

Petitioner:

Guardant Health, Inc.

Patent Owner:

Tech Center:

1. Filed: April 08, 2022 00:00

   Coverage

   1. October 11, 2023

      DNA Sequencing Patent Survives Guardant PTAB Challenge

      The Patent Trial and Appeal Board has ruled that Guardant Health failed to show that challenged claims in a University of Washington patent for DNA sequencing were unpatentable, ahead of an infringement trial set for next month.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login